The growth story Oxford OXSQ is not telling investors Technical Weakness 20260511 MGEE MGE Energy reports 98 percent Q4 2025 revenue growth shares rise 126 percent despite narrow EPS miss Bristol Myers Squibb BMY Partners With Pfizer to List Blockbuster Anticoagulant Eliquis on Mark Cuban Cost Plus Platform at 345 Monthly Regeneron Pharmaceuticals REGN Dupixent Secures FDA Approval as First Biologic for Pediatric Chronic Spontaneous Urticaria Expanding Blockbuster Drugs Addressable Market Pimco PTY releases quarterly earnings as key financial metrics remain undisclosed to investors NWE Q1 2026 Earnings EPS Beat Fails to Impress Shares Edge Lower FWDI Q1 2026 Earnings Strong EPS Beat Drives Profitability Despite Revenue Uncertainty GRDN Q1 2026 Earnings EPS Misses Estimates Despite Positive Stock Reaction SVCO Q1 2026 Earnings BetterThanExpected Loss Drives Modest Stock Gain Biohaven BHVN Q1 2026 Earnings EPS Slightly Misses Estimates as Pipeline Momentum Builds